CBER Biologics Effectiveness and Safety (BEST) System
This is the main page for CBER's Biologics Effectiveness and Safety (BEST) System.
‘I Am Going Through Hell’: Job Loss, Mental Health, and the Fate of Federal Workers
The National Institutes of Health employee said she knew things would be difficult for federal workers after Donald Trump was elected. But she never imagined…
The Bakery Group Issues Allergen Alert on Undeclared Milk, Soy and Yellow FD&C #5 In Specific Bread and Hamburger Buns
The Bakery Group of Dallas, Tx is recalling 629 cases of Dense Brioche Pullman loaves, #654203 and 104 cases of 4.5in Brioche HB Buns, #54500 because …
Her service, her story: ACP helps women Veterans find meaningful employment
Since 2010, more than 36,000 individuals have benefited from ACP's mentorship program, which equips Veterans and military spouses with the tools and r…
Resources for You (Biologics)
Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, …
Center for Biologics Evaluation and Research Patient Engagement Program
Patient input is a critical part of CBER’s understanding of diseases and conditions. Engaging with patients and listening to their perspectives on t…
Update: COVID-19 Vaccine Booster Composition
FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) held a virtual meeting on June 28, 2022, to publicly discuss whether a ch…
Bill That Congressman Says Protects Medicaid Doesn’t — And Would Likely Require Cutting It
“On Feb. 25, I voted yes on a budget resolution that protects Social Security, Medicare, and Medicaid while cutting some spending elsewhere.” Rep. Nick LaLota…
